2 results
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Alectinib versus ... Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Durvalumab after ... #EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM